Re: The original point
in response to
by
Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: The original point
Miles,
Do you remember posting how excited you were about Patriot's new ventures and the MMP didn't matter too much to you any longer? Have you changed your position? Are you now (once again) expecting the revenues from the MMP to increase the stock price and have you written off any potential for the ventures?
New Message
Please
login
to post a reply